World Cancer Day is this Sunday, February 4.
An opportunity for patients to focus on a range of recent advances.
TF1info has selected three, which are related to disease treatment, prevention and professional field respectively.
Characterized by the proliferation of malignant cells, cancer affects five continents and all population groups, although the oldest are more affected. The number of deaths from the disease is estimated at 9.74 million for the year 2022 by IARC, which is expected to increase by about 90% by 2050. As a measure, for every hundred deaths, the average is 56 men 44. women
In addition to the key figures released by the WHO to mark the World Day, celebrated this Sunday, February 4 this year, the date is also an opportunity to focus on some major advances as a symbol of hope for patients.
A promising vaccine against pancreatic cancer
One of them concerns vaccine research, particularly in the area of ​​pancreatic cancer. While several vaccines designed to prevent the risk of recurrence of this type of cancer are currently undergoing clinical trials, one of them, ELI-002 2P, was the subject of publication in the newspaper. Nature Medicine On 9 January.
Developed by American firm Eliseo Therapeutics, the product helps train the immune system to recognize mutations in the KRAS gene, particularly common in pancreatic cancer, Details world, That echoed this promising progress this week. The results of these first clinical trials are specifically designed to ensure that the vaccine is safe.
Capital search by CNRS against breast cancer
For its part, the National Center for Scientific Research (CNRS) announced on its website that a study conducted by a Franco-American team led by it revealed the essential role played by proteins in the development of metastases in aggressive or aggressive women. Treatment-refractory breast cancer. The manager? SMYD2 is present in all cells in our body, but in much higher numbers in these forms of cancer.
Crucially, the discovery could revolutionize the fight against breast cancer, one in five of which metastasizes.
Recognition of cancer as an occupational disease
Finally, on January 15 in Grand Est, a woman’s breast cancer was recognized as an occupational disease. The person concerned, whose case was brought by the National Union of Miners CFDT, is a former employee of the private hospital of the Caisse des Mines in Framing-Merlebec in the Moselle. He is only the seventh person in France to receive this recognition.
-
Also read
Cancer: 77% rise in cases between 2022 and 2050, WHO warns
As a reminder, according to studies by Inserm and Anses, night work, radiation and toxic products are three recognized risk factors for breast cancer. Patients who think their breast cancer is linked to their professional activity are invited to contact the national agency to help them compile a file.
(TagsToTranslate) Diseases and Treatments
Source link
